Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex.

Source:http://linkedlifedata.com/resource/pubmed/id/11303041

Download in:

View as

General Info

PMID
11303041